113 related articles for article (PubMed ID: 38322666)
1. Peripheral Blood CD8
Wang S; Mu X; Wang X; Chen L; Lu C; Song L
Clin Med Insights Oncol; 2024; 18():11795549241227421. PubMed ID: 38322666
[TBL] [Abstract][Full Text] [Related]
2. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
Ao M; Li P; Sun D; Li X; Xu S; Hao Y
J Obstet Gynaecol; 2023 Dec; 43(1):2179915. PubMed ID: 37001548
[TBL] [Abstract][Full Text] [Related]
3. The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
Li R; Liu Y; Yin R; Yin L; Li K; Sun C; Zhou Z; Li P; Tong R; Xue J; Lu Y
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1432-1441. PubMed ID: 33713744
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy.
Zhang Y; Zhang Z; Zhang L; Zhao S; Zhao J; Ye Q; Gao Y; Jiang C; Cui D; Xia S; Han B; Jing Y
Urol J; 2020 May; 17(3):257-261. PubMed ID: 31630384
[TBL] [Abstract][Full Text] [Related]
6. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
7. Circulating CD8
Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
[TBL] [Abstract][Full Text] [Related]
8. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy-Induced CD4
Chen X; Zhang W; Qian D; Guan Y; Wang Y; Zhang H; Er P; Yan C; Li Y; Ren X; Pang Q; Wang P
Front Oncol; 2019; 9():73. PubMed ID: 30828566
[No Abstract] [Full Text] [Related]
10. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.
Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y
Front Oncol; 2023; 13():1195848. PubMed ID: 37346066
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocyte counts in patients with infectious mononucleosis or chronic active Epstein-Barr virus infection and prognostic risk factors of chronic active Epstein-Barr virus infection.
Lin J; Chen X; Wu H; Chen X; Hu X; Xu J
Am J Transl Res; 2021; 13(11):12797-12806. PubMed ID: 34956494
[TBL] [Abstract][Full Text] [Related]
12. Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.
Huang C; Ding J; Huang C; Yu L; Chitapanarux I; Mejia MBA; Fei Z; Chen C
Transl Cancer Res; 2023 Dec; 12(12):3718-3727. PubMed ID: 38192995
[TBL] [Abstract][Full Text] [Related]
13. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
Geng R; Tang H; You T; Xu X; Li S; Li Z; Liu Y; Qiu W; Zhou N; Li N; Ge Y; Guo F; Sun Y; Wang Y; Li T; Bai C
Front Immunol; 2023; 14():1125876. PubMed ID: 36969245
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of changes of peripheral blood T cell subsets after thermoradiotherapy for nasopharyngeal carcinoma].
Qiu YR; Zheng L; Yang CL; Wei D; Sun DH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):818-20. PubMed ID: 15257913
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
Front Immunol; 2018; 9():727. PubMed ID: 29910795
[TBL] [Abstract][Full Text] [Related]
16. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
Han S; Zhang C; Li Q; Dong J; Liu Y; Huang Y; Jiang T; Wu A
Br J Cancer; 2014 May; 110(10):2560-8. PubMed ID: 24691423
[TBL] [Abstract][Full Text] [Related]
17. Analysis of peripheral blood lymphocyte subsets in critical patients at ICU admission: A preliminary investigation of their role in the prediction of sepsis during ICU stay.
Frattari A; Polilli E; Primiterra V; Savini V; Ursini T; Di Iorio G; Parruti G
Int J Immunopathol Pharmacol; 2018; 32():2058738418792310. PubMed ID: 30114952
[TBL] [Abstract][Full Text] [Related]
18. Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.
Ye S; Chen W; Zheng Y; Wu Y; Xiang L; Li T; Ping B; Zhang X; Yang H
J Ovarian Res; 2022 Apr; 15(1):43. PubMed ID: 35410290
[TBL] [Abstract][Full Text] [Related]
19. High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy.
Xu X; Wei F; Xiao L; Wu R; Wei B; Huang S; Yi J; Cui W
J Transl Med; 2023 Jan; 21(1):64. PubMed ID: 36721233
[TBL] [Abstract][Full Text] [Related]
20. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Li M; Xu J; Jiang C; Zhang J; Sun T
Front Oncol; 2022; 12():842705. PubMed ID: 35242718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
